Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
1077
-
Total 13F shares, excl. options
-
92.2M
-
Shares change
-
+2.17M
-
Total reported value, excl. options
-
$64.4B
-
Value change
-
+$1.54B
-
Put/Call ratio
-
1.66
-
Number of buys
-
489
-
Number of sells
-
-502
-
Price
-
$698.42
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2022
1,248 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2022.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,077 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.2M shares
of 105M outstanding shares and own 87.81% of the company stock.
Largest 10 shareholders include FMR LLC (9.98M shares), BlackRock Inc. (9.58M shares), VANGUARD GROUP INC (8.36M shares), Capital World Investors (5.95M shares), STATE STREET CORP (5.13M shares), JPMORGAN CHASE & CO (4.96M shares), WELLINGTON MANAGEMENT GROUP LLP (2.89M shares), LOOMIS SAYLES & CO L P (2.55M shares), Dodge & Cox (2.24M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.09M shares).
This table shows the top 1077 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.